Prevalencia de cardiopatías congénitas con diagnóstico prenatal en una IPS de la ciudad de Bucaramanga
| datacite.rights | http://purl.org/coar/access_right/c_16ec | |
| dc.contributor.advisor | Rueda Ordoñez, Carol Gisela | |
| dc.contributor.advisor | Noguera Machacón, Luz Mery | |
| dc.contributor.author | Rosas Arévalo, Daniela Alejandra | |
| dc.contributor.author | Carrascal Arenas, Marisol | |
| dc.date.accessioned | 2024-01-17T19:08:11Z | |
| dc.date.available | 2024-01-17T19:08:11Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Las cardiopatías congénitas constituyen una anomalía grave que compromete al corazón o a los grandes vasos intratorácicos que presentan o potencialmente tienen el riesgo de un compromiso funcional miocárdico, en trastornos de oxigenación y perfusión posterior al nacimiento. Objetivo: Determinar la prevalencia de cardiopatías congénitas con diagnóstico prenatal en una IPS de la ciudad de Bucaramanga. Materiales y métodos: Estudio tipo descriptivo de corte transversal y retrospectivo que permite observar la realidad existente, describir los procesos y resultados obtenidos basados en reportes de ecocardiografía fetal de una IPS de la ciudad de Bucaramanga y datos telefónicos obtenidos a través de llamadas telefónicas. Estos datos se consolidaron en una base de datos de Excel, la cual se utilizó para sacar cada uno de los resultados. Resultados: La cardiopatía más prevalente en la población estudiada fue la comunicación interventricular. Dentro de los hallazgos ecográficos a nivel prenatal que llevaron al diagnóstico de cardiopatía congénita fueron la sospecha de anormalidad estructural, regurgitación tricuspídea y anormalidad en el ductus venoso como las principales indicaciones. Las gestantes que se encontraban entre los 26 a 35 años, fueron a quienes se les indicó la realización de ecocardiogramas fetales, el antecedente con hijo de cardiopatía congénita tuvo mayor porcentaje como factor de riesgo que el antecedente personal de cardiopatía congénita, y pese a que la prevalencia de cardiopatía asociada a diabetes fue mínima, como indicación tanto la diabetes gestacional como la diabetes gestacional, presentaron un gran porcentaje. La mayoría de sospecha diagnóstica de cardiopatías congénitas se realizó en segundo trimestre a través de la ecografía de detalle anatómico. Conclusión: El tamizaje tanto de primer como de segundo trimestre por medio de la ecografía de tamizaje genético y de detalle anatómico, permiten la sospecha de cardiopatías congénitas en la población general, lo que lleva a realización de ecocardiograma fetal como método diagnóstico de cardiopatías congénitas antenatales. | spa |
| dc.description.abstract | Congenital heart diseases constitute a serious anomaly that compromises the heart or the large intrathoracic vessels that present or potentially have the risk of myocardial functional compromise, in oxygenation and perfusion disorders after birth. Objective: Determine the prevalence of congenital heart diseases with prenatal diagnosis in an IPS in the city of Bucaramanga. Materials and methods: Descriptive cross-sectional and retrospective study that allows observing the existing reality, describing the processes and results obtained based on fetal echocardiography reports from an IPS in the city of Bucaramanga and telephone data obtained through telephone calls. These data were consolidated in an Excel database, which was used to obtain each of the results. Results: The most prevalent heart disease in the studied population was ventricular septal defect. Among the prenatal ultrasound findings that led to the diagnosis of congenital heart disease were the suspicion of structural abnormality, tricuspid regurgitation and abnormality in the ductus venosus as the main indications. Pregnant women who were between 26 and 35 years old were those who were indicated to perform fetal echocardiograms; the history of congenital heart disease with their child had a higher percentage as a risk factor than the personal history of congenital heart disease, and although The prevalence of heart disease associated with diabetes was minimal; as an indication, both gestational diabetes and gestational diabetes presented a large percentage. The majority of suspected diagnoses of congenital heart disease were made in the second trimester through anatomical detail ultrasound. Conclusion: Screening in both the first and second trimester through ultrasound for genetic screening and anatomical detail allows the suspicion of congenital heart disease in the general population, which leads to fetal echocardiography as a diagnostic method for prenatal congenital heart disease. | eng |
| dc.format.mimetype | ||
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/13804 | |
| dc.language.iso | spa | |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Cardiopatía congénita | spa |
| dc.subject | Tamizaje de cardiopatía | spa |
| dc.subject | Ecocardiografía fetal | spa |
| dc.subject | Congenital heart disease | eng |
| dc.subject | Heart disease screening | eng |
| dc.subject | Fetal echocardiography | eng |
| dc.title | Prevalencia de cardiopatías congénitas con diagnóstico prenatal en una IPS de la ciudad de Bucaramanga | spa |
| dc.type.driver | info:eu-repo/semantics/other | |
| dc.type.spa | Otros | |
| dcterms.references | Peña-Juarez RA, Corona-Villalobos CA, Medina-Andrade MA, Garrido-García L, Gutierrez-Torpey C, Mier-Martínez M. Presentación y manejo de las cardiopatías congénitas en el primer año de edad. Arch Cardiol Mex. 2021 Aug 24;91(3). | spa |
| dcterms.references | Meller CH, Grinenco S, Aiello H, Córdoba A, Sáenz-Tejeira MM, Marantz P, et al. Congenital heart disease, prenatal diagnosis and management. Arch Argent Pediatr. 2020;118:E149–61. | eng |
| dcterms.references | Abuhamad A, Chaoui R. Practical Guide to Fetal Echocardiography, A: Normal and Abnormal Hearts. 4th ed. Lippincott Williams & Wilkins, editor. Filadelfia; 2022. | eng |
| dcterms.references | Karim JN, Bradburn E, Roberts N, Papageorghiou AT, Alfirevic Z, Chudleigh T, et al. First-trimester ultrasound detection of fetal heart anomalies: systematic review and meta-analysis. Vol. 59, Ultrasound in Obstetrics and Gynecology. John Wiley and Sons Ltd; 2022. p. 11–25. | eng |
| dcterms.references | Andrade C. Major Congenital Malformations Associated With Exposure to Second-Generation Antipsychotic Drugs During Pregnancy. Journal of Clinical Psychiatry. 2021 Sep 1;82(5):1–3. | eng |
| dcterms.references | Pinheiro DO, Varisco BB, Silva MB Da, Duarte RS, Deliberali GD, Maia CR, et al. Accuracy of Prenatal Diagnosis of Congenital Cardiac Malformations. Revista Brasileira de Ginecologia e Obstetricia. 2019 Jan 14;41(1):11–6. | eng |
| dcterms.references | Yu D, Sui L, Zhang N. Performance of First-Trimester Fetal Echocardiography in Diagnosing Fetal Heart Defects: Meta-analysis and Systematic Review. Journal of Ultrasound in Medicine. 2020 Mar 1;39(3):471–80. | eng |
| dcterms.references | Minnella GP, Crupano FM, Syngelaki A, Zidere V, Akolekar R, Nicolaides KH. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus. Ultrasound in Obstetrics and Gynecology. 2020 May 1;55(5):637–44. | eng |
| dcterms.references | Huhta JC. First-trimester screening for congenital heart disease. Vol. 31, Current Opinion in Cardiology. Lippincott Williams and Wilkins; 2016. p. 72–7. | eng |
| dcterms.references | Reyes Hernández MU. Cardiopatías congénitas: características y beneficios del diagnóstico prenatal. Acta Médica Grupo Ángeles. 2023;21(1):60–5. | spa |
| dcterms.references | Castaño SP. DEFECTOS CONGÉNITOS. 2020. | spa |
| dcterms.references | Copado Mendoza DY, Martínez García AJ, Acevedo Gallegos S. Importancia del diagnóstico prenatal de las cardiopatías congénitas. Perinatol Reprod Hum. 2018 Sep;32(3):127–30. | spa |
| dcterms.references | Muñoz H, Enríquez G, Ortega X, Pinto M, Hosiasson S, Germain A, et al. Congenital heart disease diagnosis: routine screening, fetal echocardiography and precision medicine. Vol. 34, Revista Medica Clinica Las Condes. Ediciones Doyma, S.L.; 2023. p. 44–56. | eng |
| dcterms.references | Ecocardiografia-fetal-en-ginecobstetricia. | spa |
| dcterms.references | Kazelian P, Borda ME, Aguilar M, Casale R. Detección prenatal de cardiopatías congénitas y factores relacionados. Experiencia en un hospital nacional. Prensa méd argent [Internet]. 2019 [cited 2023 Sep 28];105(6):340–6. Available from: prensamedica.com.ar/ | spa |
| dcterms.references | Torres-Romucho CE, Uriondo-Ore VG, Ramirez-Palomino AJ, Arroyo-Hernández H, Loo-Valverde M, Protzel-Pinedo A, et al. Factors associated with survival at one year of life in neonates with severe congenital cardiopathy in a national hospital in Peru. Rev Peru Med Exp Salud Publica. 2019;36(3):433–41. | eng |
| dcterms.references | Martínez García A de J, Apolonio Martínez A, Copado Mendoza Y, Acevedo Gallegos S. Diagnóstico prenatal y del recién nacido con cardiopatía congénita crítica: los tres pilares del tamiz cardiaco. Revista CONAMED. 2023;28(1):37–45. | spa |
| dcterms.references | Eckersley L, Sadler L, Parry E, Finucane K, Gentles TL. Timing of diagnosis affects mortality in critical congenital heart disease. Arch Dis Child. 2016 Jun 1;101(6):516–20. | eng |
| dcterms.references | Gómez-Monroy CA, Hoyos-Gómez LK, Acosta-Costilla ÁF, Muñoz-Torres LD, Fernández-Ávila DG. Prevalencia de las cardiopatías congénitas en relación con la altura sobre el nivel del mar en una región de Colombia. Arch Cardiol Mex. 2023 Jan 1;93(1):37–43. | spa |
| dcterms.references | Madrid A, Restrepo JP. CARDIOPATIAS CONGÉNITAS 1 2. | spa |
| dcterms.references | Kilbaugh TJ, Zwass MS, Ross P. Cuidados intensivos pediátricos y neonatales [Internet]. 2021. Available from: www.iculiberation.org. | spa |
| dcterms.references | Bravo-valenzuela NJ, Peixoto AB, Araujo Júnior E. Prenatal diagnosis of congenital heart disease: A review of current knowledge. Vol. 70, Indian Heart Journal. Elsevier B.V.; 2018. p. 150–64. | eng |
| dcterms.references | AIUM Practice Parameter for the Performance of Fetal Echocardiography. Vol. 39, Journal of Ultrasound in Medicine. John Wiley and Sons Ltd.; 2020. p. E5–16. | eng |
| dcterms.references | Scala C, Morlando M, Familiari A, Leone Roberti Maggiore U, Ferrero S, D’Antonio F, et al. Fetal Tricuspid Regurgitation in the First Trimester as a Screening Marker for Congenital Heart Defects: Systematic Review and Meta-Analysis. Vol. 42, Fetal Diagnosis and Therapy. S. Karger AG; 2017. p. 1–8. | eng |
| dcterms.references | Li T gang, Wang G, Xie F, Yao J min, Yang L, Wang M lin, et al. Prenatal diagnosis of single umbilical artery and postpartum outcome. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2020 Nov 1;254:6–10. | eng |
| dcterms.references | Huang T, Rashid S, Mak-Tam E, Priston M, Gibbons C, Bedford M, et al. 517 Prenatal screening for pre-eclampsia using PlGF and SFlt-1 in the early second trimester. S338 American Journal of Obstetrics & Gynecology Supplement. 2022. | eng |
| dcterms.references | Maruotti GM, Saccone G, Ciardulli A, Mazzarelli LL, Berghella V, Martinelli P. Absent ductus venosus: case series from two tertiary centres. Vol. 31, Journal of Maternal-Fetal and Neonatal Medicine. Taylor and Francis Ltd; 2018. p. 2478–83. | eng |
| dcterms.references | Maduro C, Castro LF De, Moleiro ML, Guedes-Martins L. Pregestational Diabetes and Congenital Heart Defects. Revista Brasileira de Ginecologia e Obstetricia. 2022 Oct 1;44(10):953–61. | eng |
| dcterms.references | Giraldo-Grueso M, Zarante I, Mejía-Grueso A, Gracia G. Risk factors for congenital heart disease: A case-control study. Revista Colombiana de Cardiologia. 2020 Jul 1;27(4):324–9. | eng |
| dcterms.references | Gullo G, Scaglione M, Laganà AS, Perino A, Andrisani A, Chiantera V, et al. Assisted Reproductive Techniques and Risk of Congenital Heart Diseases in Children: a Systematic Review and Meta-analysis. Reproductive Sciences. Institute for Ionics; 2023. | eng |
| dcterms.references | madre epilepticas | spa |
| dcterms.references | Cohen JM, Alvestad S, Cesta CE, Bjørk MH, Leinonen MK, Nørgaard M, et al. Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations. Ann Neurol. 2023 Mar 1;93(3):551–62. | eng |
| dcterms.references | Los Inhibidores de la Enzima Convertidora de Angiotensina (IECA) [Internet]. Available from: https://mothertobaby.org/fact-sheets/paternal-exposures-pregnancy/. | spa |
| dcterms.references | Portela Torrón F. Embriología, anatomía quirúrgica, evolución. Cirugía Cardiovascular. 2014;21(2):74–8. | spa |
| dcterms.references | Pediatria-Integral-XXV-8_WEB embriología cardiaca. | spa |
| dcterms.references | Ford SM, Watanabe M, Devaney EJ. Cardiac Embryology Overview of Normal Heart Development. | eng |
| dcterms.references | Shah H, Bourne T, Hardy K. 3 Embryology Oogenesis and Spermatogenesis. | eng |
| dcterms.references | ISUOG Practice Guidelines (updated): performance of 11–14-week ultrasound scan. Vol. 61, Ultrasound in Obstetrics and Gynecology. John Wiley and Sons Ltd; 2023. p. 127–43. | eng |
| dcterms.references | Salomon LJ, Alfirevic Z, Berghella V, Bilardo C, Hernandez-Andrade E, Johnsen SL, et al. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound in Obstetrics and Gynecology. 2011 Jan;37(1):116–26. | eng |
| dcterms.references | Carvalho JS, Axt-Fliedner R, Chaoui R, Copel JA, Cuneo BF, Goff D, et al. ISUOG Practice Guidelines (updated): fetal cardiac screening. Vol. 61, Ultrasound in Obstetrics and Gynecology. John Wiley and Sons Ltd; 2023. p. 788–803. | eng |
| dcterms.references | Reyes-Hernández MU, Bermúdez-Rentería LG, Cifuentes-Fernández EF, Hinojosa-Cruz JC. Adverse perinatal outcomes in fetuses with prenatal diagnosis of congenital heart disease. Ginecol Obstet Mex. 2021 Jul 1;89(7):516–23. | eng |
| dcterms.references | Armas López M, Sierra RE, Collado YR, Sucet K, Armas E. Morbilidad y mortalidad neonatal por cardiopatías congénitas Neonatal morbidity and mortality by congenital cardiopathies [Internet]. Vol. 91, Revista Cubana de Pediatría. 2019. Available from: http://scielo.sld.cuhttp://scielo.sld.cu | eng |
| dcterms.references | Prats P, Ferrer Q, Rodríguez MA, Comas C. Prenatal diagnosis and outcome of congenital heart diseases. Diagnostico Prenatal. 2011;22(4):128–35. | eng |
| dcterms.references | Clemades A, Rodriguez L, Salazar A. Cardiopatías congénitas en el recién nacido [Caracterización de neonatos con cardiopatía congénita]. [Santa Clara]: Hospital Universitario Gineco-obstétrico Mariana Grajales; 2019. | spa |
| dcterms.references | Cruz-Lemini M, Nieto-Castro B, Luna-Garcia J, Juarez-Martinez I, Martínez-Rivera M, Bermudez-Rojas M de la L, et al. Prenatal diagnosis of congenital heart defects: experience of the first Fetal Cardiology Unit in Mexico. Journal of Maternal-Fetal and Neonatal Medicine. 2021;34(10):1529–34. | eng |
| dcterms.references | Gill HK, Splitt M, Sharland GK, Simpson JM. Patterns of recurrence of congenital heart disease: An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol. 2003 Sep 3;42(5):923–9. | eng |
| dcterms.references | Lisowski LA, Verheijen PM, Copel JA, Kleinman CS, Wassink S, Visser GHA, et al. Congenital heart disease in pregnancies complicated by maternal diabetes mellitus: An international clinical collaboration, literature review, and meta-analysis. Herz. 2010 Jan;35(1):19–26. | eng |
| dcterms.references | Belfrage K, Richards B, Corbitt R, Hersey D, Texter K, Stiver C, et al. Initial fetal to initial postnatal echocardiogram in uncomplicated atrioventricular septal defects: Do significant changes occur? Echocardiography. 2020 Dec 1;37(12):2102–6. | eng |
| dcterms.references | Scala C, Morlando M, Familiari A, Leone Roberti Maggiore U, Ferrero S, D’Antonio F, et al. Fetal Tricuspid Regurgitation in the First Trimester as a Screening Marker for Congenital Heart Defects: Systematic Review and Meta-Analysis. Vol. 42, Fetal Diagnosis and Therapy. S. Karger AG; 2017. p. 1–8. | eng |
| dcterms.references | van Nisselrooij AEL, Teunissen AKK, Clur SA, Rozendaal L, Pajkrt E, Linskens IH, et al. Why are congenital heart defects being missed? Ultrasound in Obstetrics and Gynecology. 2020 Jun 1;55(6):747–57. | eng |
| dcterms.references | Copel JA, Cullen M, Green JJ, et al, The frecuency of aneuploidy in prenatally diagnosed congenital heart disease: an indication for fetal karyotyping. Am J Obstet Gynecol 1988; 158:409-413. | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | |
| sb.programa | Especialización en Ginecología y Obstetricia | spa |
| sb.sede | Sede Barranquilla | spa |